Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study aimed to compare intravitreous conbercept alone with conbercept plus intravitreous
triamcinolone acetonide in DME eyes which showed limited response to anti-VEGF treatment
after one injection.
Phase:
N/A
Details
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University